- Home
- PLX vs FGBI Comparison
PLX vs FGBI Comparison
Compare PLX & FGBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- FGBI
- Stock Information
- Founded
- PLX 1993
- FGBI 1934
- Country
- PLX United States
- FGBI United States
- Employees
- PLX N/A
- FGBI N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- FGBI Savings Institutions
- Sector
- PLX Health Care
- FGBI Finance
- Exchange
- PLX Nasdaq
- FGBI Nasdaq
- Market Cap
- PLX 127.4M
- FGBI 121.5M
- IPO Year
- PLX 1998
- FGBI N/A
- Fundamental
- Price
- PLX $1.55
- FGBI $8.05
- Analyst Decision
- PLX Strong Buy
- FGBI
- Analyst Count
- PLX 1
- FGBI 0
- Target Price
- PLX $15.00
- FGBI N/A
- AVG Volume (30 Days)
- PLX 571.5K
- FGBI 5.7K
- Earning Date
- PLX 08-14-2025
- FGBI 08-18-2025
- Dividend Yield
- PLX N/A
- FGBI 0.50%
- EPS Growth
- PLX N/A
- FGBI N/A
- EPS
- PLX 0.08
- FGBI N/A
- Revenue
- PLX $61,948,000.00
- FGBI $59,070,000.00
- Revenue This Year
- PLX $14.53
- FGBI N/A
- Revenue Next Year
- PLX $75.77
- FGBI $3.38
- P/E Ratio
- PLX $20.34
- FGBI N/A
- Revenue Growth
- PLX 62.79
- FGBI N/A
- 52 Week Low
- PLX $0.89
- FGBI $6.56
- 52 Week High
- PLX $3.10
- FGBI $15.25
- Technical
- Relative Strength Index (RSI)
- PLX 47.97
- FGBI 43.01
- Support Level
- PLX $1.47
- FGBI $7.78
- Resistance Level
- PLX $1.57
- FGBI $8.09
- Average True Range (ATR)
- PLX 0.07
- FGBI 0.18
- MACD
- PLX -0.00
- FGBI 0.00
- Stochastic Oscillator
- PLX 31.82
- FGBI 29.51
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About FGBI First Guaranty Bancshares Inc.
First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.